ARCHIMED to acquire ZimVie for $730m.

ARCHIMED, an investment firm focused exclusively on healthcare industries, agreed to acquire ZimVie, a life sciences leader in the dental implant market, for $730m. “This transaction marks a new chapter for ZimVie and underscores the value our team has built over the past several years. Partnering with ARCHIMED will create value for our shareholders while providing the strategic and financial backing to expand our innovative dental technology to more patients globally," Vafa Jamali, ZimVie Chairman of the Board and Chief Executive Officer.